Wells Fargo reiterates Buy on HLF; $21 target
The Buy rating and target imply meaningful stated upside, but this is an analyst opinion rather than a fundamental catalyst.
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
The Buy rating and target imply meaningful stated upside, but this is an analyst opinion rather than a fundamental catalyst.
What happened, with direct paths to the underlying reporting
The report says Wells Fargo reiterated a Buy rating on Herbalife and lists a $21 target against a posted price of $15.96.
Target: $21
Posted price: $15.96
Analyst firm: Wells Fargo
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.